While the ability to deliberately engineer pathogens has been constrained to high-end labs run by top researchers, the technology to achieve this is rapidly becoming cheaper and more widespread.[4] For example, the diminishing cost of sequencing the human genome (from $10 million to $1,000), the accumulation of large datasets of genetic information, the discovery of gene drives, and the discovery of CRISPR.[5] Biotechnology risk is therefore a credible explanation for the Fermi paradox.[6]
^Ali Noun; Christopher F. Chyba (2008). "Chapter 20: Biotechnology and biosecurity". In Bostrom, Nick; Cirkovic, Milan M. (eds.). Global Catastrophic Risks. Oxford University Press.
^Bostrom, Nick; Cirkovic, Milan M. (29 September 2011). Global Catastrophic Risks: Nick Bostrom, Milan M. Cirkovic: 9780199606504: Amazon.com: Books. OUP Oxford. ISBN978-0199606504 – via Amazon.com.